Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed.
Medical - Care Facilities
DE, Bad Homburg vor der Höhe [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -7.35 | 20.00 | 21.59 | |
| Graham Fair Price | -31.93 | 19.58 | 28.76 | |
| PEG | 32.91 | -0.02 | -0.03 | |
| Price/Book | -12.76 | 0.18 | 0.21 | |
| Price/Cash Flow | 456.15 | -17.15 | 3.08 | |
| Prices/Earnings | 97.19 | 3.16 | -1.60 | |
| Price/Sales | -11.13 | 0.62 | 0.69 | |
| Price/FCF | 456.15 | -17.15 | 3.08 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 7.91 | 0.25 | 0.23 | |
| Operating Margin | 202.42 | 0.10 | 0.03 | |
| ROA | -53.70 | < 0.005 | -0.01 | |
| ROE | -0.03 | 0.01 | -55.76 | |
| ROIC | 0.03 | 0.01 | -56.26 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.08 | 0.05 | 77.34 | |
| Dividends QOQ | -0.98 | -1.00 | -1.78 | |
| EBIT QOQ | -0.47 | 2.04 | 335.29 | |
| EPS QOQ | -0.49 | 1.45 | 193.93 | |
| FCF QOQ | -0.04 | -1.16 | -2980.05 | |
| Revenue QOQ | 0.03 | < 0.005 | -84.21 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Weak
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 51.71 | 55.26 | 6.87 | |
| Days Sales Outstanding (DSO) | 95.53 | 63.56 | -33.47 | |
| Inventory Turnover | 1.74 | 1.63 | -6.43 | |
| Debt/Capitalization | 0.42 | 0.40 | -6.91 | |
| Quick Ratio | 0.92 | 0.60 | -34.61 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Bad
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 33.73 | 34.52 | 2.34 | |
| Cash | 4.56 | 1.81 | -60.37 | |
| Capex | -0.73 | -0.37 | 49.51 | |
| Free Cash Flow | 2.27 | -0.36 | -83.95 | |
| Revenue | 10.08 | 10.13 | 0.46 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Weak
Fundamentals
Financial Health
06 - Financial Health ·
Weak